153 related articles for article (PubMed ID: 7759865)
61. Transcriptional up-regulation of the cyclin D2 gene and acquisition of new cyclin-dependent kinase partners in human T-cell leukemia virus type 1-infected cells.
Santiago F; Clark E; Chong S; Molina C; Mozafari F; Mahieux R; Fujii M; Azimi N; Kashanchi F
J Virol; 1999 Dec; 73(12):9917-27. PubMed ID: 10559304
[TBL] [Abstract][Full Text] [Related]
62. CDK4 expression and activity are required for cytokine responsiveness in T cells.
Modiano JF; Mayor J; Ball C; Fuentes MK; Linthicum DS
J Immunol; 2000 Dec; 165(12):6693-702. PubMed ID: 11120786
[TBL] [Abstract][Full Text] [Related]
63. A cyclin D-Cdk4 activity required for G2 phase cell cycle progression is inhibited in ultraviolet radiation-induced G2 phase delay.
Gabrielli BG; Sarcevic B; Sinnamon J; Walker G; Castellano M; Wang XQ; Ellem KA
J Biol Chem; 1999 May; 274(20):13961-9. PubMed ID: 10318807
[TBL] [Abstract][Full Text] [Related]
64. Notch signaling mediates G1/S cell-cycle progression in T cells via cyclin D3 and its dependent kinases.
Joshi I; Minter LM; Telfer J; Demarest RM; Capobianco AJ; Aster JC; Sicinski P; Fauq A; Golde TE; Osborne BA
Blood; 2009 Feb; 113(8):1689-98. PubMed ID: 19001083
[TBL] [Abstract][Full Text] [Related]
65. Differential regulation of cyclin-dependent kinase 4 (CDK4) and CDK6, evidence that CDK4 might not be activated by CDK7, and design of a CDK6 activating mutation.
Bockstaele L; Bisteau X; Paternot S; Roger PP
Mol Cell Biol; 2009 Aug; 29(15):4188-200. PubMed ID: 19487459
[TBL] [Abstract][Full Text] [Related]
66. Early induction of cyclin D2 expression in phorbol ester-responsive B-1 lymphocytes.
Tanguay DA; Colarusso TP; Pavlovic S; Irigoyen M; Howard RG; Bartek J; Chiles TC; Rothstein TL
J Exp Med; 1999 Jun; 189(11):1685-90. PubMed ID: 10359571
[TBL] [Abstract][Full Text] [Related]
67. Cigarette tar phenols impede T cell cycle progression by inhibiting cyclin-dependent kinases.
Frazer-Abel AA; McCue JM; Lazis S; Portas M; Lambert C; Freed BM
Mol Immunol; 2007 Jan; 44(4):488-93. PubMed ID: 16584776
[TBL] [Abstract][Full Text] [Related]
68. Cutting edge: differential signaling requirements for activation of assembled cyclin D3-cdk4 complexes in B-1 and B-2 lymphocyte subsets.
Tanguay DA; Colarusso TP; Doughty C; Pavlovic-Ewers S; Rothstein TL; Chiles TC
J Immunol; 2001 Apr; 166(7):4273-7. PubMed ID: 11254678
[TBL] [Abstract][Full Text] [Related]
69. Oncogenic stimulation recruits cyclin-dependent kinase in the cell cycle start in rat fibroblast.
Jinno S; Hung SC; Yamamoto H; Lin J; Nagata A; Okayama H
Proc Natl Acad Sci U S A; 1999 Nov; 96(23):13197-202. PubMed ID: 10557297
[TBL] [Abstract][Full Text] [Related]
70. D cyclins in lymphocytes.
Kaplan D; Meyerson H; Husel W; Lewandowska K; MacLennan G
Cytometry A; 2005; 63(1):1-9. PubMed ID: 15619730
[TBL] [Abstract][Full Text] [Related]
71. Independent regulation of human D-type cyclin gene expression during G1 phase in primary human T lymphocytes.
Ajchenbaum F; Ando K; DeCaprio JA; Griffin JD
J Biol Chem; 1993 Feb; 268(6):4113-9. PubMed ID: 8382693
[TBL] [Abstract][Full Text] [Related]
72. D-type cyclins.
Sherr CJ
Trends Biochem Sci; 1995 May; 20(5):187-90. PubMed ID: 7610482
[TBL] [Abstract][Full Text] [Related]
73. Activation and proliferation signals in primary human T lymphocytes inhibited by ergosterol peroxide isolated from Cordyceps cicadae.
Kuo YC; Weng SC; Chou CJ; Chang TT; Tsai WJ
Br J Pharmacol; 2003 Nov; 140(5):895-906. PubMed ID: 14504132
[TBL] [Abstract][Full Text] [Related]
74. The Trypanosoma cruzi immunosuppressive factor (TIF) targets a lymphocyte activation event subsequent to increased intracellular calcium ion concentration and translocation of protein kinase C but previous to cyclin D2 and cdk4 mRNA accumulation.
Kierszenbaum F; Majumder S; Paredes P; Tanner MK; Sztein MB
Mol Biochem Parasitol; 1998 Apr; 92(1):133-45. PubMed ID: 9574917
[TBL] [Abstract][Full Text] [Related]
75. All-trans retinoic acid stimulates IL-2-mediated proliferation of human T lymphocytes: early induction of cyclin D3.
Engedal N; Gjevik T; Blomhoff R; Blomhoff HK
J Immunol; 2006 Sep; 177(5):2851-61. PubMed ID: 16920920
[TBL] [Abstract][Full Text] [Related]
76. The metabolic function of cyclin D3-CDK6 kinase in cancer cell survival.
Wang H; Nicolay BN; Chick JM; Gao X; Geng Y; Ren H; Gao H; Yang G; Williams JA; Suski JM; Keibler MA; Sicinska E; Gerdemann U; Haining WN; Roberts TM; Polyak K; Gygi SP; Dyson NJ; Sicinski P
Nature; 2017 Jun; 546(7658):426-430. PubMed ID: 28607489
[TBL] [Abstract][Full Text] [Related]
77. Cyclin D and cisplatin cytotoxicity in primary neuroblastoma cell lines.
Zhang L; Plon SE; Nuchtern JG; Burlingame S; Blaney S; Rousseau R; Berg S
Anticancer Drugs; 2004 Oct; 15(9):883-8. PubMed ID: 15457129
[TBL] [Abstract][Full Text] [Related]
78. Cyclin D3 and p53 mediate sulforaphane-induced cell cycle delay and apoptosis in non-transformed human T lymphocytes.
Fimognari C; Nüsse M; Berti F; Iori R; Cantelli-Forti G; Hrelia P
Cell Mol Life Sci; 2002 Nov; 59(11):2004-12. PubMed ID: 12530531
[TBL] [Abstract][Full Text] [Related]
79. Overexpression of cyclin D2 in chronic B-cell malignancies.
Delmer A; Ajchenbaum-Cymbalista F; Tang R; Ramond S; Faussat AM; Marie JP; Zittoun R
Blood; 1995 May; 85(10):2870-6. PubMed ID: 7742549
[TBL] [Abstract][Full Text] [Related]
80. Assay for activity of mammalian cyclin D-dependent kinases CDK4 and CDK6.
Phelps DE; Xiong Y
Methods Enzymol; 1997; 283():194-205. PubMed ID: 9251020
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
